Shuttle Pharmaceuticals Holdings, Inc. SHPH
4.01
0.01
0.25%
as of 25 Sep
- Market cap
- $15.6M
- P/E
- 34.7×
Follow SHPH
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
3.07 | 1.66 | 0.06 | 0.30 |
Net Debt/EBITDA |
1.24 | 0.93 | 0.13 | 0.69 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.91 | 1.12 | 0.37 | 1.12 | |
Capex/Depreciation |
0.00 | 0.00 | (10.09) | (0.06) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.94 | 0.78 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(29.80) | (11.76) | (24.60) | (4.88) | |
Cash per Share |
42.79 | 9.38 | 2.04 | 2.17 | |
Shareholders Equity per Share |
32.02 | 6.24 | 13.76 | 6.65 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
32.02 | 6.24 | 13.76 | 6.65 | |
Free Cash Flow |
(3.36) | (2.63) | (4.03) | (2.45) | |
Working Capital |
3.50 | 1.30 | (7.46) | (5.84) | |
Capital Expenditures |
— | — | (3.06) | (0.04) | |
Net Current Asset Value |
3.29 | 1.12 | (7.72) | (6.00) | |
| Other line items | |||||
Quick Ratio |
2.85 | 1.07 | 0.04 | 0.13 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(29.80) | (11.76) | (5.94) | (4.80) | |
Capex per Share |
0.00 | 0.00 | (18.66) | (0.07) | |
Average Payables |
0.77 | 1.41 | 1.03 | 1.34 | |
Average Assets |
4.16 | 2.11 | 6.49 | 8.56 | |
Average Common Equity |
2.20 | 0.04 | 1.48 | 3.32 | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates